Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

VistaGen Therapeutics, Inc. (VSTA) Featured in Seeking Alpha Article

A recent article published by Seeking Alpha, titled “Supreme Court Decision Is Bullish For Stem Cell Companies,” reviews the recent high court decision that allows medical universities and science foundations to receive federal funding for embryonic stem cell research. Now … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

MetaStat, Inc. (MTST) is “One to Watch”

MetaStat, a life science company focused on treating systemic metastasis, is focused on becoming an industry leader in the emerging field of personalized cancer therapy. Its proprietary platform technologies are the result of more than 15 years of collaboration with … Continue reading

Posted in Ones to Watch | Leave a comment

FAB Universal Corp. (FU) Signs Deal with Antaeus to Expand Retail Operations

FAB Universal announced that the company had signed a deal with Antaeus Cinema and Shouhang Supermarkets that would see FAB-branded retail mini stores in their locations. The FAB locations will allow customers of Antaeus and Shouhang the opportunity to download … Continue reading

Posted in Small Cap News | Leave a comment

James Bartholomew Joins Le Cordon Bleu North America as President

Le Cordon Bleu North America, a division of Career Education Corp. (NASDAQ: CECO) announced that it has a new president, Mr. James Bartholomew. He will be based at Career Education’s Campus Support Center in Schaumburg, IL. Le Cordon Bleu is … Continue reading

Posted in Small Cap News | Leave a comment

Hansen Medical’s (HNSN) Magellan Robotic System Utilized in Two Successful Live Cases at 25th Annual ISET

Yesterday, global intravascular robotics leader Hansen Medical announced that its Magellan Robotic System was utilized in two successful live endovascular aortic aneurysm repair (EVAR) cases. Both cases were performed by Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami) Founder … Continue reading

Posted in Small Cap News | Leave a comment

Stellar Biotechnologies Inc. (SBOTF) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Stellar Biotechnologies produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and KLH subunit formulations in the United States and Europe. The company’s KLH is an immunogenic high-molecular-weight protein, … Continue reading

Posted in Noble Equity Conference | Leave a comment

Cumulus Media Inc. (CMLS) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Cumulus Media owns and operates commercial radio station clusters throughout the United States. The company has approximately 525 stations in 110 markets, a fully distributed programming network serving more than 4,500 affiliates nationwide and SweetJack, a local deals platform. CMLS … Continue reading

Posted in Noble Equity Conference | Leave a comment

VistaGen Therapeutics Inc. (VSTA) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

VistaGen Therapeutics is focused on applying human pluripotent stem cell technology for drug rescue and cell therapy. The company’s Human Clinical Trials in a Test Tube is a pluripotent stem cell technology platform for predictive toxicology, drug development, and drug … Continue reading

Posted in Noble Equity Conference | Leave a comment

Electro Scientific Industries Inc. (ESIO) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Electro Scientific Industries is engaged in high-technology manufacturing equipment for the microtechnology industry. Its advanced laser systems enable structuring and testing of micron to submicron features in components and devices which are used in a variety of end products in … Continue reading

Posted in Noble Equity Conference | Leave a comment

Medistem Inc. (MEDS) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Medistem is focused on the development of the Endometrial Regenerative Cell (ERC), a universal donor adult stem cell product that possesses specialized abilities to stimulate new blood vessel growth and can differentiate into nine different tissues. These unique properties have … Continue reading

Posted in Noble Equity Conference | Leave a comment